SCANSOURCE, INC. 10-Q

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations Overview ScanSource is a leading hybrid distributor connecting devices to the cloud and accelerating growth for customers and channel partners across hardware, software as a service ("SaaS"), and connectivity and cloud services. ScanSource uses multiple sales 27 Table of Contents models to offer hybrid distribution solutions from leading suppliers of specialty technologies and connectivity and cloud services. The Company operates in the United States, Canada and Brazil. We operate our business under a management structure that enhances our specialty technology focus and hybrid distribution growth strategy. Our segments operate in the United States, Canada and Brazil and are based on sales models: • Specialty Technology Solutions • Intelisys & Advisory We offer hardware, SaaS, and connectivity and cloud services from leading technology suppliers to customers and channel partners enabling solutions for users' needs and challenges. We operate distribution facilities that support our United States and Canada business in Mississippi, California and Kentucky. Brazil distribution facilities are located in the Brazilian states of Paraná, Espirito Santo and Santa Catarina. We provide some of our digital products, which include SaaS and subscriptions, through our digital tools and platforms. Recent Developments Impact of the Macroeconomic Environment, Including Growth Outlook, Inflation and Tariffs The macroeconomic environment, including the economic impacts of growth outlook, inflation, tariffs and shifting relations between the U.S. and other countries , continues to create significant uncertainty and may adversely affect our financial condition and results of operations. In 2025, the U.S. announced a variety of additional tariffs on goods from multiple nations and trading blocks and has been targeted with reciprocal tariffs and other retaliatory actions in response. Although the U.S. has announced a 90-day pause on certain tariffs, negotiations and the state of international trade policy and relations continue to evolve. We are mindful of the potential impact these conditions could have on our customers, suppliers and end-customer demand and w e are actively monitoring changes to the global macroeconomic environment and assessing the potential impacts these challenges may have on our financial condition, results of operations and liquidity. We expect to pass any price increases from our suppliers resulting from tariffs to our customers. W e are also mitigating risks through strategic planning and maintaining financial flexibility , but we cannot predict the outcome of our mitigation strategies or the ultimate impact of tariffs and the global macroeconomic environment on our financial condition or results of operations . Business Acquisitions On August 8, 2024, we completed the acquisition of substantially all of the assets of Secure Path Networks, LLC doing business as Resourcive ("Resourcive"), a leading technology advisor. Resourcive delivers strategic IT sourcing solutions to mid-market and enterprise businesses. On August 15, 2024, we completed the acquisition of substantially all of the assets of Advantix Solutions Group, Inc. ("Advantix"), a managed connectivity experience provider specializing in wireless enablement solutions. Restructuring In September 2024, as part of a strategic review of organizational structure and operations, the Company executed a cost reduction and restructuring program to align our cost structure with demand expectations in our hardware business. These actions are expected to result in approximately $10.5 million in annualized savings in selling, general and administrative expenses. Our Strategy Our strategy is to drive sustainable, profitable growth by orchestrating hybrid technology solutions through a growing ecosystem of partners by leveraging our people, processes and tools. Our goal is to provide exceptional experiences for our customers, suppliers and employees through operational excellence. Our hybrid distribution strategy utilizes multiple sales models to offer hardware, SaaS, and connectivity and cloud services from leading technology suppliers to customers that solve end-users’ challenges. ScanSource enables customers to deliver solutions for their end-users to address changing buying and consumption patterns. Our solutions may include a combination of offerings from multiple suppliers or give our customers access to additional services. As a trusted adviser to our customers, we provide solutions through our strong understanding of end-user needs. 28 Table of Contents Results of Operations Net Sales We have two reportable segments, which are based on sales channels. The following tables summarize our net sales results by operating segment and by geographic location for the quarters and nine months ended March 31, 2025 and 2024: Quarter ended March 31, % Change, Constant Currency, Excluding Divestitures and Acquisitions (a) Net Sales by Segment: 2025 2024 $ Change % Change (in thousands) Specialty Technology Solutions $ 678,433 $ 729,834 $ (51,401) (7.0) % (6.8) % Intelisys & Advisory 26,414 22,765 3,649 16.0 % 4.3 % Total net sales $ 704,847 $ 752,599 $ (47,752) (6.3) % (6.4) % Nine months ended March 31, % Change, Constant Currency, Excluding Divestitures and Acquisitions (a) 2025 2024 $ Change % Change (in thousands) Specialty Technology Solutions $ 2,154,009 $ 2,445,298 $ (291,289) (11.9) % (11.3) % Intelisys & Advisory 73,915 68,398 5,517 8.1 % 0.9 % Total net sales $ 2,227,924 $ 2,513,696 $ (285,772) (11.4) % (11.0) % (a) A reconciliation of non-GAAP net sales in constant currency, excluding divestitures and acquisitions, is presented at the end of Results of Operations , under Non-GAAP Financial Information. Specialty Technology Solutions The Specialty Technology Solutions segment consists of sales to channel partners in the United States, Canada and Brazil. For the quarter and nine months ended March 31, 2025, net sales decreased $51.4 million, or 7.0%, and $291.3 million, or 11.9%, respectively, compared to the prior-year periods. Excluding the impact from foreign exchange rate fluctuations and the impact of divestitures and acquisitions, adjusted net sales decreased $49.4 million , or 6.8%, and $276.3 million, or 11.3%, respectively, compared to the prior-year periods. For the quarter e nded March 31, 2025, net sales decreased primarily due to lower net sales in Brazil. In North America, most of the technologies in this segment had year-over-year growth. For the nine months ended March 31, 2025, net sales decreased primarily due to soft demand in a more cautious technology spending environment. Intelisys & Advisory The Intelisys & Advisory segment consists of sales and services to both channel partners (Intelisys) and end-users (Advisory) in the United States. For the quarter ended March 31, 2025, net sales increased $3.6 million, or 16.0%, compared to the prior-year period. Excluding the impact from foreign exchange rate fluctuations and the impact of acquisitions, adjusted net sales increased $1.0 million, or 4.3% for the quarter ended March 31, 2025. For the nine months ended March 31, 2025, net sales increased $5.5 million, or 8.1%, compared to the prior-year period. Excluding the impact from foreign exchange rate fluctuations and the impact of acquisitions, adjusted net sales increased $0.6 million, or 0.9% for the nine months ende d March 31, 2025. The increase in net sales for the quarter and nine months ended March 31, 2025 reflects the addition of an acquisition and Intelisys net sales growth. Quarterly net billings for Intelisys increased 6.8% over the prior-year quarter to bring annualized net billings to approximately $2.86 billion. 29 Table of Contents Quarter ended March 31, % Change, Constant Currency, Excluding Divestitures and Acquisitions (a) Net Sales by Geography: 2025 2024 $ Change % Change (in thousands) United States and Canada $ 656,964 $ 671,246 $ (14,282) (2.1) % (3.5) % Brazil (b) 47,883 81,353 (33,470) (41.1) % (30.4) % Total net sales $ 704,847 $ 752,599 $ (47,752) (6.3) % (6.4) % Nine months ended March 31, % Change, Constant Currency, Excluding Divestitures and Acquisitions (a) 2025 2024 $ Change % Change (in thousands) United States and Canada $ 2,056,094 $ 2,257,629 $ (201,535) (8.9) % (9.9) % Brazil (b) 171,830 256,067 (84,237) (32.9) % (20.7) % Total net sales $ 2,227,924 $ 2,513,696 $ (285,772) (11.4) % (11.0) % (a) A reconciliation of non-GAAP net sales in constant currency is presented at the end of Results of Operations in the non-GAAP section. (b) Countries outside of Brazil represent $0.1 million, or 0.2% of sales, and $0.3 million, or 0.2% of sales, for the quarter and nine months ended March 31, 2025, respectively. Countries outside of Brazil represent $0.1 million, or 0.2% of sales, and $4.3 million, or 1.7% of sales, for the quarter and nine months ended March 31, 2024, respectively. 30 Table of Contents Gross Profit The following table summarizes our gross profit for the quarters and nine months ended March 31, 2025 and 2024: Quarter ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 (in thousands) Specialty Technology Solutions $ 73,994 $ 71,840 $ 2,154 3.0 % 10.9 % 9.8 % Intelisys & Advisory 26,208 22,641 3,567 15.8 % 99.2 % 99.5 % Gross profit $ 100,202 $ 94,481 $ 5,721 6.1 % 14.2 % 12.6 % Nine months ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 (in thousands) Specialty Technology Solutions $ 230,215 $ 233,695 $ (3,480) (1.5) % 10.7 % 9.6 % Intelisys & Advisory 73,329 68,043 5,286 7.8 % 99.2 % 99.5 % Gross profit $ 303,544 $ 301,738 $ 1,806 0.6 % 13.6 % 12.0 % Our gross profit is primarily affected by sales volume and gross margin mix. Gross margin mix is impacted by multiple factors, which include sales mix (proportion of sales of higher margin products or services relative to total sales), vendor program recognition (consisting of volume rebates, inventory price changes and purchase discounts) and freight costs. Increases in vendor program recognition decrease cost of goods sold, thereby increasing gross profit. Net sales derived from our Intelisys business contribute 100% to our gross profit dollars and margin as they have no associated cost of goods sold. Specialty Technology Solutions For the quarter ended March 31, 2025, gross profit dollars for the Specialty Technology Solutions segment increased $2.2 million, or 3.0%, compared to the prior-year quarter. Vendor program recognition positively impacted gross profit by $7.2 million, offsetting the impact of lower sales volumes of $5.0 million. Gross profit margin increased 106 basis points over the prior-year quarter to 10.9%. For the nine months ended March 31, 2025, gross profit dollars decreased $3.5 million, or 1.5%, compared to the prior-year period. Lower sales volume reduced gross profit dollars by $27.8 million. Gross margin mix positively impacted gross profit by $24.3 million largely due to higher vendor program recognition and a more favorable sales mix. Gross profit margin increased 113 basis points year-over-year to 10.7%. Intelisys & Advisory For the quarter ended March 31, 2025, gross profit dollars for the Intelisys & Advisory segment increased $3.6 million, or 15.8%, compared to the prior-year quarter. Higher sales volume, largely due to the impact of our Resourcive acquisition, increased gross profit for the quarter. Gross profit margin decreased 24 basis points compared to the prior-year quarter to 99.2%, reflecting the addition of professional services to the sales mix. For the nine months ended March 31, 2025, gross profit dollars increased $5.3 million, or 7.8%, compared to the prior-year period. Higher sales volume, largely due to the acquisition of Resourcive, increased gross profit for the nine-month period. Gross profit margin decreased 27 basis points compared to the prior-year nine-month period to 99.2%, reflecting the addition of professional services to the sales mix. Operating Expenses The following table summarizes our operating expenses for the quarters and nine months ended March 31, 2025 and 2024: 31 Table of Contents Quarter ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 (in thousands) Selling, general and administrative expenses $ 69,698 $ 66,574 $ 3,124 4.7 % 9.9 % 8.8 % Depreciation expense 2,320 2,690 (370) (13.8) % 0.3 % 0.4 % Intangible amortization expense 4,941 3,752 1,189 31.7 % 0.7 % 0.5 % Restructuring and other charges — 3,923 (3,923) (100.0) % 0.0 % 0.5 % Change in fair value of contingent consideration 904 — 904 *nm 0.1 % 0.0 % Operating expenses $ 77,863 $ 76,939 $ 924 1.2 % 11.0 % 10.2 % Nine months ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 (in thousands) Selling, general and administrative expenses $ 215,324 $ 208,930 $ 6,394 3.1 % 9.7 % 8.3 % Depreciation expense 8,079 8,449 (370) (4.4) % 0.4 % 0.3 % Intangible amortization expense 14,300 11,982 2,318 19.3 % 0.6 % 0.5 % Restructuring and other charges 5,381 3,923 1,458 37.2 % 0.2 % 0.2 % Change in fair value of contingent consideration 2,047 — 2,047 *nm 0.1 % 0.0 % Operating expenses $ 245,131 $ 233,284 $ 11,847 5.1 % 11.0 % 9.3 % Selling, general and administrative expenses (“SG&A”) increased by $3.1 million, or 4.7%, and $6.4 million, or 3.1% for the quarter and nine months ended March 31, 2025, respectively compared to the prior-year periods. The increase for the quarter is primarily attributable to increased costs related to acquisitions. The increase for the nine-month period is primarily attributable to increased costs related to acquisitions as well as increased customer specific bad debt expense. The increase in amortization expense of $1.2 million and $2.3 million during the quarter and nine months ended March 31, 2025, respectively, is largely due to intangible assets acquired in our acquisitions of Advantix and Resourcive. Restructuring and other charges of $5.4 million were incurred during the nine months ended March 31, 2025 compared to charges of $3.9 million for the quarter and nine months ended March 31, 2024. Restructuring and other charges relate to employee separation and benefit costs in connection with our expense reduction and restructuring plans implemented during the current and prior fiscal year. We present changes in fair value of the contingent consideration owed to the former shareholders of businesses that we acquire as a separate line item in operating expenses. We recorded a fair value adjustment expense of $0.9 million and $2.0 million in the quarter and nine months ended March 31, 2025, respectively. The expense from changes in fair value of contingent consideration for the quarter and nine months is largely due to the recurring amortization of the unrecognized fair value discount. 32 Table of Contents Operating Income The following table summarizes our operating income for the quarters and nine months ended March 31, 2025 and 2024: Quarter ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 (in thousands) Specialty Technology Solutions $ 14,294 $ 14,580 $ (286) (2.0) % 2.1 % 2.0 % Intelisys & Advisory 8,320 7,489 831 11.1 % 31.5 % 32.9 % Corporate (275) (4,527) 4,252 nm* nm* nm* Operating income $ 22,339 $ 17,542 $ 4,797 27.3 % 3.2 % 2.3 % Nine months ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 (in thousands) Specialty Technology Solutions $ 45,110 $ 51,914 $ (6,804) (13.1) % 2.1 % 2.1 % Intelisys & Advisory 21,173 22,411 (1,238) (5.5) % 28.6 % 32.8 % Corporate (7,870) (5,871) (1,999) nm* nm* nm* Operating income $ 58,413 $ 68,454 $ (10,041) (14.7) % 2.6 % 2.7 % *nm - percentages are not meaningful Specialty Technology Solutions For the Specialty Technology Solutions segment, operating income decreased $0.3 million, or 2.0%, and $6.8 million, or 13.1% for the quarter and nine months ended March 31, 2025 , respectively, compared to the prior-year periods. Operating margin was 2.1% for the quarter and nine months ended March 31, 2025. The decrease in operating income for the quarter is primarily due to higher amortization expense related to a recent acquisition. The decrease in operating income for the nine months is primarily due to lower gross profits from lower sales volumes as well as higher bad debt expense. Intelisys & Advisory For the Intelisys & Advisory segment, operating income increased $0.8 million, or 11.1%, for the quarter ended March 31, 2025. Operating margin decreased to 31.5% for the quarter ended March 31, 2025. The increase in operating income for the quarter ended March 31, 2025 is a result of higher gross profits for the quarter. For the nine months ended March 31, 2025, operating income decreased $1.2 million, or 5.5%, compared to the prior-year period. Operating margin decreased to 28.6% for the nine months ended March 31, 2025. The decrease in operating income for the nine-month period ended March 31, 2025 is primarily driven by expense related to the change in fair value of contingent consideration. Corporate For the quarter and nine months ended March 31, 2025, Corporate operating losses of $0.3 million and $7.9 million, respectively, represent restructuring and acquisition-related costs and a legal settlement incurred during the fiscal year. Total Other (Income) Expense The following table summarizes our total other (income) expense for the quarters and nine months ended March 31, 2025 and 2024: 33 Table of Contents Quarter ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 (in thousands) Interest expense $ 1,836 $ 2,001 $ (165) (8.2) % 0.3 % 0.3 % Interest income (2,841) (2,652) (189) 7.1 % (0.4) % (0.4) % Net foreign exchange losses 130 508 (378) (74.4) % 0.0 % 0.1 % Other, net (1,012) (267) (745) 279.0 % (0.1) % (0.0) % Total other (income) expense, net $ (1,887) $ (410) $ (1,477) 360.2 % (0.3) % (0.1) % Nine months ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 (in thousands) Interest expense $ 5,914 $ 10,947 $ (5,033) (46.0) % 0.3 % 0.4 % Interest income (8,193) (6,096) (2,097) 34.4 % (0.4) % (0.2) % Net foreign exchange losses 212 1,632 (1,420) (87.0) % 0.0 % 0.1 % Gain on sale of business — (14,533) 14,533 nm* — % (0.6) % Other, net (6,418) (641) (5,777) nm* (0.3) % (0.0) % Total other (income) expense, net $ (8,485) $ (8,691) $ 206 (2.4) % (0.4) % (0.3) % *nm - percentages are not meaningful Interest expense consists primarily of interest incurred on borrowings, non-utilization fees charged on the revolving credit facility and amortization of debt issuance costs. Interest expense decreased for the quarter and nine months ended March 31, 2025 compared to the prior-year periods, primarily from lower average borrowings on our multi-currency revolving credit facility. Interest income increased for the quarter and nine months ended March 31, 2025 primarily from interest earned on higher average cash balances in the United States. Net foreign exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign exchange forward contracts gains and losses. Foreign exchange gains and losses are generated as the result of fluctuations in the value of the U.S. dollar versus the Brazilian real, the Canadian dollar versus the U.S. dollar, the euro versus the U.S. dollar, and the British pound versus the U.S. dollar. We partially offset foreign currency exposure with the use of foreign exchange contracts to hedge against these exposures. The costs associated with foreign exchange forward contracts are included in the net foreign exchange losses. For the quarter and nine months ended March 31, 2025, we recognized a gain of $1.0 million and $6.4 million, respectively, primarily as a result of an insurance recovery in connection with the cybersecurity attack in the fourth quarter of fiscal year 2023. Provision for Income Taxes For the quarter and nine months ended March 31, 2025, income tax expense was $6.8 million and $15.4 million, respectively, reflecting an effective tax rate of 28.0% and 23.1%. In comparison, for the quarter and nine months ended March 31, 2024, income tax expense was $5.1 million and $16.2 million reflecting an effective tax rate of 28.7% and 21.0%, respectively. The decrease in the effective tax rate for the quarter is primarily driven by a change in the geographical mix of earnings. The increase in the effective tax rate for the nine-month period is primarily due to the higher amount of discrete tax benefits recognized in the prior-year period. We expect the effective tax rate, excluding discrete items, for fiscal year 2025 to be approximately 28.2% to 29.2%. See Note 13 - Income Taxes to the Notes to Consolidated Financial Statements for further discussion. 34 Table of Contents Non-GAAP Financial Information Evaluating Financial Condition and Operating Performance In addition to disclosing results that are determined in accordance with United States generally accepted accounting principles (“US GAAP” or “GAAP”), we also disclose certain non-GAAP financial measures. These measures include non-GAAP operating income; non-GAAP pre-tax income; non-GAAP net income; non-GAAP EPS; adjusted earnings before interest expense, income taxes, depreciation, and amortization (“adjusted EBITDA”); adjusted return on invested capital (“adjusted ROIC”); and constant currency. Constant currency is a measure that excludes the translation exchange impact from changes in foreign currency exchange rates between reporting periods. We use non-GAAP financial measures to better understand and evaluate performance, including comparisons from period to period. These non-GAAP financial measures have limitations as analytical tools, and the non-GAAP financial measures that we report may not be comparable to similarly titled amounts reported by other companies. Analysis of results and outlook on a non-GAAP basis should be considered in addition to, and not in substitution for or as superior to, measurements of financial performance prepared in accordance with US GAAP. Adjusted Return on Invested Capital Adjusted ROIC assists us in comparing our performance over various reporting periods on a consistent basis because it removes from our operating results the impact of items that do not reflect our core operating performance. We believe the calculation of adjusted ROIC provides useful information to investors and is an additional relevant comparison of our performance during the year. Adjusted EBITDA starts with net income and adds back interest expense, income tax expense, depreciation expense, amortization of intangible assets, share-based compensation expense, and other non-GAAP adjustments. Since adjusted EBITDA excludes some non-cash costs of investing in our business and people, we believe that adjusted EBITDA shows the profitability from our business operations more clearly. We calculate adjusted ROIC as adjusted EBITDA, divided by invested capital. Invested capital is defined as average equity plus average daily funded interest-bearing debt for the period. The following table summarizes annualized adjusted ROIC for the quarters ended March 31, 2025 and 2024, respectively: Quarter ended March 31, 2025 2024 Adjusted return on invested capital ratio, annualized (a) 13.6 % 12.1 % (a) The annualized EBITDA amount is divided by days in the quarter times 365 days per year, or 366 days for leap year. There were 90 days in the current and 91 days in the prior-year quarter. The components of this calculation and reconciliation to our financial statements are shown on the following schedule: 35 Table of Contents Quarter ended March 31, 2025 2024 (in thousands) Reconciliation of net income to adjusted EBITDA: Net income (GAAP) $ 17,431 $ 12,806 Plus: Interest expense 1,836 2,001 Plus: Income taxes 6,795 5,146 Plus: Depreciation and amortization 7,492 6,742 EBITDA (non-GAAP) 33,554 26,695 Plus: Change in fair value of contingent consideration 904 — Plus: Share-based compensation 2,896 2,388 Plus: Acquisition and divestiture costs (a) 204 511 Plus: Cyberattack restoration costs 71 93 Plus: Restructuring costs — 3,923 Plus: Tax recovery (1,820) (515) Plus: Insurance recovery, net of payments (756) — Adjusted EBITDA (numerator for adjusted ROIC) (non-GAAP) $ 35,053 $ 33,095 Quarter ended March 31, 2025 2024 (in thousands) Invested capital calculations: Equity – beginning of the quarter $ 900,662 $ 953,601 Equity – end of the quarter 901,746 944,051 Plus: Change in fair value of contingent consideration, net of tax 681 — Plus: Share-based compensation, net 2,176 1,784 Plus: Acquisition and divestiture costs (a) 204 511 Plus: Cyberattack restoration costs, net 54 69 Plus: Restructuring, net — 2,935 Plus: Insurance recovery, net of payments (570) — Plus: Tax recovery, net (1,201) (1,648) Average equity 901,876 950,652 Average funded debt (b) 140,207 153,131 Invested capital (denominator for adjusted ROIC) (non-GAAP) $ 1,042,083 $ 1,103,783 (a) Acquisition and divestiture costs are generally non-deductible for tax purposes. (b) Average funded debt is calculated as the daily average amounts outstanding on our short-term and long-term interest-bearing debt. Net Sales in Constant Currency Excluding Acquisitions and Divestitures We make references to “constant currency,” a non-GAAP performance measure that excludes the foreign exchange rate impact from fluctuations in the average foreign exchange rates between reporting periods. Constant currency is calculated by translating current period results from currencies other than the U.S. dollar into U.S. dollars using the comparable average foreign exchange rates from the prior-year period. We also exclude the impact of acquisitions or divestitures prior to the first full year of operations from the acquisition or divestiture date in order to show net sales results on an organic basis. This information is provided to analyze underlying trends without the translation impact of fluctuations in foreign currency rates and the impact of acquisitions and divestitures. Below we show organic growth by providing a non-GAAP reconciliation of net sales in constant currency excluding acquisitions and divestitures: 36 Table of Contents Net Sales by Segment: Quarter ended March 31, 2025 2024 $ Change % Change Specialty Technology Solutions: (in thousands) Net sales, reported $ 678,433 $ 729,834 $ (51,401) (7.0) % Foreign exchange impact (a) 8,702 — Less: Acquisitions (6,660) — Non-GAAP net sales $ 680,475 $ 729,834 $ (49,359) (6.8) % Intelisys & Advisory: Net sales, reported $ 26,414 $ 22,765 $ 3,649 16.0 % Foreign exchange impact (a) 3 — Less: Acquisitions (2,662) — Non-GAAP net sales $ 23,755 $ 22,765 $ 990 4.3 % Consolidated: Net sales, reported $ 704,847 $ 752,599 $ (47,752) (6.3) % Foreign exchange impact (a) 8,705 — Less: Acquisitions (9,322) — Non-GAAP net sales $ 704,230 $ 752,599 $ (48,369) (6.4) % (a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended March 31, 2024. 37 Table of Contents Net Sales by Segment: Nine months ended March 31, 2025 2024 $ Change % Change Specialty Technology Solutions (in thousands) Net sales, reported $ 2,154,009 $ 2,445,298 $ (291,289) (11.9) % Foreign exchange impact (a) 28,070 — Less: Divestitures — (4,019) Less: Acquisitions (17,059) — Non-GAAP net sales $ 2,165,020 $ 2,441,279 $ (276,259) (11.3) % Intelisys & Advisory Net sales, reported $ 73,915 $ 68,398 $ 5,517 8.1 % Foreign exchange impact (a) (5) — Less: Acquisitions (4,924) — Non-GAAP net sales $ 68,986 $ 68,398 $ 588 0.9 % Consolidated: Net sales, reported $ 2,227,924 $ 2,513,696 $ (285,772) (11.4) % Foreign exchange impact (a) 28,065 — Less: Divestitures — (4,019) Less: Acquisitions (21,983) — Non-GAAP net sales $ 2,234,006 $ 2,509,677 $ (275,671) (11.0) % (a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the nine months ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the nine months ended March 31, 2024. 38 Table of Contents Net Sales by Geography: Quarter ended March 31, 2025 2024 $ Change % Change United States and Canada: (in thousands) Net sales, as reported $ 656,964 $ 671,246 $ (14,282) (2.1) % Less: Acquisitions (9,322) — Non-GAAP net sales $ 647,642 $ 671,246 $ (23,604) (3.5) % Brazil: Net sales, reported (a) $ 47,883 $ 81,353 $ (33,470) (41.1) % Foreign exchange impact (b) 8,705 — Non-GAAP net sales, constant currency $ 56,588 $ 81,353 $ (24,765) (30.4) % Consolidated: Net sales, reported (a) $ 704,847 $ 752,599 $ (47,752) (6.3) % Foreign exchange impact (b) 8,705 — Less: Acquisitions (9,322) — Non-GAAP net sales, constant currency $ 704,230 $ 752,599 $ (48,369) (6.4) % (a) Countries outside of Brazil represent $0.1 million, or 0.2% of sales, for the quarter ended March 31, 2025 and $0.1 million, or 0.2% of sales, for the quarter ended March 31, 2024. (b) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended March 31, 2024. Nine months ended March 31, 2025 2024 $ Change % Change United States and Canada: (in thousands) Net sales, as reported $ 2,056,094 $ 2,257,629 $ (201,535) (8.9) % Less: Acquisitions (21,983) — Non-GAAP net sales 2,034,111 2,257,629 $ (223,518) (9.9) % Brazil: Net sales, reported (a) $ 171,830 $ 256,067 $ (84,237) (32.9) % Foreign exchange impact (b) 28,065 — Less: Divestitures — (4,019) Non-GAAP net sales, constant currency $ 199,895 $ 252,048 $ (52,153) (20.7) % Consolidated: Net sales, reported $ 2,227,924 $ 2,513,696 $ (285,772) (11.4) % Foreign exchange impact (b) 28,065 — Less: Divestitures — (4,019) Less: Acquisitions (21,983) — Non-GAAP net sales, constant currency $ 2,234,006 $ 2,509,677 $ (275,671) (11.0) % (a) Countries outside of Brazil represent $0.3 million, or 0.2% of sales, for the nine months ended March 31, 2025 and $4.3 million, or 1.7% of sales, for the nine months ended March 31, 2024. (b) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the nine months ended March 31, 2025 into U.S. dollars using the average foreign exchange rates for the nine months ended March 31, 2024. 39 Table of Contents Operating Income by Segment: Quarter ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 Specialty Technology Solutions: (in thousands) GAAP operating income $ 14,294 $ 14,580 $ (286) (2.0) % 2.1 % 2.0 % Adjustments: Amortization of intangible assets 2,753 1,828 925 Change in fair value of contingent consideration 94 — 94 Tax recovery, net (1,820) (515) (1,305) Non-GAAP operating income $ 15,321 $ 15,893 $ (572) (3.6) % 2.3 % 2.2 % Intelisys & Advisory: GAAP operating income $ 8,320 $ 7,489 $ 831 11.1 % 31.5 % 32.9 % Adjustments: Amortization of intangible assets 2,188 1,924 264 Change in fair value of contingent consideration 810 — 810 Non-GAAP operating income $ 11,318 $ 9,413 $ 1,905 20.2 % 42.8 % 41.3 % Corporate: GAAP operating loss $ (275) $ (4,527) $ 4,252 nm* nm* nm* Adjustments: Acquisition and divestiture costs 204 511 (307) Restructuring costs — 3,923 (3,923) Cyberattack restoration costs 71 93 (22) Non-GAAP operating income $ — $ — $ — nm* nm* nm* Consolidated: GAAP operating income $ 22,339 $ 17,542 $ 4,797 27.3 % 3.2 % 2.3 % Adjustments: Amortization of intangible assets 4,941 3,752 1,189 Change in fair value of contingent consideration 904 — 904 Tax recovery (a) (1,820) (515) (1,305) Acquisition and divestiture costs 204 511 (307) Restructuring costs — 3,923 (3,923) Cyberattack restoration costs 71 93 (22) Non-GAAP operating income $ 26,639 $ 25,306 $ 1,333 5.3 % 3.8 % 3.4 % (a) Recovery of prior period withholding taxes in Brazil. 40 Table of Contents Operating Income by Segment: Nine months ended March 31, % of Net Sales March 31, 2025 2024 $ Change % Change 2025 2024 Specialty Technology Solutions: (in thousands) GAAP operating income $ 45,110 $ 51,914 $ (6,804) (13.1) % 2.1 % 2.1 % Adjustments: Amortization of intangible assets 7,769 6,224 1,545 Change in fair value of contingent consideration 567 — 567 Tax recovery (a) (2,570) (1,901) (669) Non-GAAP operating income $ 50,876 $ 56,237 $ (5,361) (9.5) % 2.4 % 2.3 % Intelisys & Advisory: GAAP operating income $ 21,173 $ 22,411 $ (1,238) (5.5) % 28.6 % 32.8 % Adjustments: Amortization of intangible assets 6,531 5,758 773 Change in fair value of contingent consideration 1,480 — 1,480 Non-GAAP operating income $ 29,184 $ 28,169 $ 1,015 3.6 % 39.5 % 41.2 % Corporate: GAAP operating loss $ (7,870) $ (5,871) $ (1,999) nm* nm* nm* Adjustments: Cyberattack restoration costs 177 733 (556) Acquisition and divestiture costs 733 1,215 (482) Restructuring costs 5,381 3,923 1,458 Legal settlement 1,579 — 1,579 Non-GAAP operating income $ — $ — $ — nm* nm* nm* Consolidated: GAAP operating income $ 58,413 $ 68,454 $ (10,041) (14.7) % 2.6 % 2.7 % Adjustments: Amortization of intangible assets 14,300 11,982 2,318 Change in fair value of contingent consideration 2,047 — 2,047 Cyberattack restoration costs 177 733 (556) Tax recovery (a) (2,570) (1,901) (669) Acquisition and divestiture costs 733 1,215 (482) Restructuring costs 5,381 3,923 1,458 Legal settlement 1,579 — 1,579 Non-GAAP operating income $ 80,060 $ 84,406 $ (4,346) (5.1) % 3.6 % 3.4 % (a) Recovery of prior period withholding taxes in Brazil. 41 Table of Contents Additional Non-GAAP Metrics To evaluate current period performance on a more consistent basis with prior periods, we disclose non-GAAP SG&A expenses, non-GAAP operating income, non-GAAP pre-tax income, non-GAAP net income and non-GAAP diluted earnings per share. Non-GAAP results exclude amortization of intangible assets related to divestitures, cyberattack restoration costs and other non-GAAP adjustments. These year-over-year metrics include the translation impact of changes in foreign currency exchange rates. These metrics are useful in assessing and understanding our operating performance, especially when comparing results with previous periods or forecasting performance for future periods. Below we provide a non-GAAP reconciliation of the aforementioned metrics adjusted for the costs and charges mentioned above: Quarter ended March 31, 2025 GAAP Measure Intangible amortization expense Change in fair value of contingent consideration Acquisition and Divestiture costs (a) Restructuring costs Insurance recovery Tax recovery Cyberattack restoration costs Non-GAAP measure (in thousands, except per share data) SG&A expenses $ 69,698 $ — $ — $ (204) $ — $ — $ 1,820 $ (71) $ 71,243 Operating income 22,339 4,941 904 204 — — (1,820) 71 26,639 Pre-tax income 24,226 4,941 904 204 — (756) (1,820) 71 27,770 Net income 17,431 3,699 681 204 — (570) (1,201) 54 20,298 Diluted EPS $ 0.74 $ 0.16 $0.03 $ 0.01 $ — $ (0.02) $ (0.05) $ — $ 0.86 Quarter ended March 31, 2024 GAAP Measure Intangible amortization expense Change in fair value of contingent consideration Acquisition and Divestiture costs (a) Restructuring costs Insurance recovery Tax recovery Cyberattack restoration costs Non-GAAP measure (in thousands, except per share data) SG&A expenses $ 66,574 $ — $ — $ (511) $ (3,923) $ — $ 515 $ (93) $ 62,562 Operating income 17,542 3,752 — 511 3,923 — (515) 93 25,306 Pre-tax income 17,952 3,752 — 511 3,923 — (515) 93 25,716 Net income 12,806 2,788 — 511 2,935 — (1,648) 69 17,461 Diluted EPS $ 0.50 $ 0.11 $ — $ 0.02 $ 0.12 $ — $ (0.06) $ — $ 0.69 (a) Acquisition and divestiture costs for the quarters ended March 31, 2025 and 2024 are generally nondeductible for tax purposes. 42 Table of Contents Nine months ended March 31, 2025 GAAP Measure Intangible amortization expense Change in fair value of contingent consideration Acquisition and Divestiture costs (a) Restructuring costs Tax recovery Cyberattack restoration costs Insurance recovery Legal settlement Non-GAAP measure SG&A expenses $ 215,324 $ — $ — $ (733) $ — $ 2,570 $ (177) $ — $ (1,579) $ 215,405 Operating income 58,413 14,300 2,047 733 5,381 (2,570) 177 — 1,579 80,060 Pre-tax income 66,898 14,300 2,047 733 5,381 (2,570) 177 (5,624) 1,579 82,921 Net income 51,458 10,709 1,542 733 4,054 (3,761) 133 (4,237) 1,189 61,820 Diluted EPS $ 2.13 $ 0.44 $ 0.06 $ 0.03 $ 0.17 $ (0.16) $ 0.01 $ (0.18) $ 0.05 $ 2.56 Nine months ended March 31, 2024 GAAP Measure Intangible amortization expense Change in fair value of contingent consideration Acquisition and Divestiture costs (a) Restructuring costs Tax recovery Cyberattack restoration costs Insurance recovery Gain on sale of a business (b) Non-GAAP measure SG&A expenses $ 208,930 $ — $ — $ (1,215) $ (3,923) $ 1,901 $ (733) $ — $ — $ 204,960 Operating income 68,454 11,982 — 1,215 3,923 (1,901) 733 — — 84,406 Pre-tax income 77,145 11,982 — 1,215 3,923 (1,901) 733 — (14,533) 78,564 Net income 60,964 8,909 — 1,215 2,935 (2,288) 548 — (14,533) 57,750 Diluted EPS $ 2.41 $ 0.35 $ — $ 0.05 $ 0.12 $ (0.09) $ 0.02 $ — $ (0.57) $ 2.28 (a) Acquisition and divestiture costs for the nine months ended March 31, 2025 and 2024 are generally nondeductible for tax purposes. (b) Reflects gain on the sale of the UK-based intY business. This transaction resulted in a capital loss for tax purposes. The Company did not record a tax provision on the capital loss since there were no offsetting capital gains. 43 Table of Contents Liquidity and Capital Resources Our primary sources of liquidity are cash flows from operations and borrowings under our $350 million revolving credit facility. Our business requires significant investment in working capital, particularly accounts receivable and inventory, partially financed through our accounts payable to vendors, cash generated from operations and revolving lines of credit. In general, as our sales volume increases, our net investment in working capital increases, which typically results in decreased cash flow from operating activities. Conversely, when sales volume decreases, our net investment in working capital typically decreases, which typically results in increased cash flow from operating activities. Our cash and cash equivalents balance totaled $146.3 million at March 31, 2025, compared to $185.5 million at June 30, 2024, including $33.3 million and $20.0 million held outside of the United States at March 31, 2025 and June 30, 2024, respectively. Checks released but not yet cleared in the amount of $0.2 million and $5.9 million are included in accounts payable at March 31, 2025 and June 30, 2024, respectively. We conduct business primarily in the United States, Canada and Brazil where we generate and use cash. We provide for United States income taxes from the earnings of our Canadian and Brazilian subsidiaries. See Note 13 - Income Taxes in the Notes to the Consolidated Financial Statements for further discussion. Our net investment in working capital, defined as accounts receivable plus inventories less accounts payable, decreased $7.9 million to $498.3 million at March 31, 2025 from $506.2 million at June 30, 2024, primarily from decreases in inventory and accounts receivable, partially offset by lower accounts payable, as a result of lower sales volume and our focus on working capital efficiency. Our net investment in working capital is affected by several factors such as fluctuations in sales volume, net income, timing of collections from customers, increases and decreases to inventory levels and payments to vendors. Nine months ended March 31, 2025 2024 (in thousands) Cash provided by (used in): Operating activities $ 104,704 $ 316,908 Investing activities (59,873) 10,693 Financing activities (83,424) (203,941) Operating cash flows are subject to variability period over period as a result of the timing of payments related to accounts receivable, accounts payable, and other working capital items. Net cash provided by operating activities was $104.7 million and $316.9 million for the nine months ended March 31, 2025 and March 31, 2024, respectively . Cash provided by operating activities for the nine months ended March 31, 2025 is primarily attributable to net income adjusted for non-cash items plus reductions in accounts receivable and inventory partially offset by a reduction in accounts payable. Compared to March 31, 2024 , accounts receivable and inventory decreased 4.6% and 10.0% respectively, while accounts payable decreased 2.7%. The number of days sales outstanding ("DSO") was 72 days at March 31, 2025 and 71 days at March 31, 2024. Inventory turned 5.0 times during the quarter ended March 31, 2025, compared to 4.8 times in the prior-year quarter ended March 31, 2024. Cash used in investing activities for the nine months ended March 31, 2025 was $59.9 million, compared to cash provided by investing activities of $10.7 million in the prior-year period. Cash used in investing activities for the nine months ended March 31, 2025 is largely due to cash paid for acquisitions and capital expenditures. Cash provided by investing activities for the nine months ended March 31, 2024 represents the proceeds from the sale of a business offset by capital expenditures. Management expects capital expenditures for fiscal year 2025 to range from $7.0 million to $9.0 million, primarily for IT investments. For the nine months ended March 31, 2025 and March 31, 2024 , cash used in financing activities totaled $83.4 million and $203.9 million, respectively. Cash used in financing activities for the nine months ended March 31, 2025 is primarily attributable to common stock repurchases in the nine months. Cash used in financing activities for the nine months ended March 31, 2024 is primarily attributable to repayments of borrowings on the revolving credit facility. 44 Table of Contents Credit Facility We have a multi-currency senior secured credit facility with JPMorgan Chase Bank N.A., as administrative agent, and a syndicate of banks (as amended, the “Amended Credit Agreement”). On September 28, 2022, we amended and restated our Amended Credit Agreement, which includes (i) a five-year, $350 million multicurrency senior secured revolving credit facility and (ii) a five-year $150 million senior secured term loan facility. The Amended Credit Agreement extended the credit facility maturity date to September 28, 2027. In addition, pursuant to an “accordion feature,” we may increase our borrowing limits up to an additional $250 million, subject to obtaining additional credit commitments from the lenders participating in the increase. The Amended Credit Agreement allows for the issuance of up to $50 million for letters of credit. Borrowings under the Amended Credit Agreement are guaranteed by substantially all of our domestic subsidiaries and secured by substantially all of our domestic assets. Under the terms of the revolving credit facility, the payment of cash dividends is restricted. We incurred debt issuance costs of $1.4 million in connection with the amendment and restatement of the Amended Credit Agreement. These costs were capitalized to other non-current assets on the Condensed Consolidated Balance Sheets and added to the unamortized debt issuance costs from the previous credit facility. Loans denominated in U.S. dollars, other than swingline loans, bear interest at a rate per annum equal to, at our option, (i) the adjusted term SOFR or adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon our ratio of (A) total consolidated debt less up to $30 million of unrestricted domestic cash to (B) trailing four-quarter consolidated EBITDA measured as of the end of the most recent year or quarter, as applicable, for which financial statements have been delivered to the Lenders (the “leverage ratio”); or (ii) the alternate base rate plus an additional margin ranging from 0% to 0.75%, depending upon our leverage ratio, plus, if applicable, certain mandatory costs. All swingline loans denominated in U.S. dollars bear interest based upon the adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon our leverage ratio, or such other rate as agreed upon with the applicable swingline lender. The adjusted term SOFR and adjusted daily simple SOFR include a fixed credit adjustment of 0.10% over the applicable SOFR reference rate. Loans denominated in foreign currencies bear interest at a rate per annum equal to the applicable benchmark rate set forth in the Amended Credit Agreement plus an additional margin ranging from 1.00% to 1.75%, depending upon our leverage ratio plus, if applicable, certain mandatory costs. During the quarter and nine months ended March 31, 2025, our borrowings under the Amended Credit Agreement were U.S. dollar loans. The spread in effect as of March 31, 2025 was 1.00% for SOFR-based loans and 0.00% for alternate base rate loans. The commitment fee rate in effect at March 31, 2025 was 0.15%. The Amended Credit Agreement includes customary representations, warranties and affirmative and negative covenants, including financial covenants. Specifically, our Leverage Ratio must be less than or equal to 3.50 to 1.00 at all times. In addition, our Interest Coverage Ratio (as such term is defined in the Amended Credit Agreement) must be at least 3.00 to 1.00 at the end of each fiscal quarter. In the event of a default, customary remedies are available to the lenders, including acceleration and increased interest rates. We were in compliance with all covenants under the credit facility at March 31, 2025. The average daily outstanding balance on the revolving credit facility, excluding the term loan facility, during the nine month periods ended March 31, 2025 and 2024 w as $0.3 million and $94.6 million, respectively. There was $350.0 million and $349.9 million available for additional borrowings as of March 31, 2025 and June 30, 2024, respectively. The effective interest rates for the revolving line of credit were 5.45% and 6.44% as of March 31, 2025 and June 30, 2024, respectively. There were no letters of credit issued under the multi-currency revolving credit facility at March 31, 2025 or June 30, 2024. Availability to use this borrowing capacity depends upon, among other things, the levels of our Leverage Ratio and Interest Coverage Ratio, which, in turn, will depend upon (1) our Credit Facility Net Debt relative to our Credit Facility EBITDA and (2) Credit Facility EBITDA relative to total interest expense, respectively. As a result, our availability will increase if EBITDA increases (subject to the limit of the facility) and decrease if EBITDA decreases. While we were in compliance with the financial covenants contained in the Amended Credit Agreement as of March 31, 2025, and currently expect to continue to maintain such compliance, should we encounter difficulties, our historical relationship with our Amended Credit Agreement lending group has been strong and we anticipate their continued support of our long-term business. Summary We believe that our existing sources of liquidity, including cash resources and cash provided by operating activities, supplemented as necessary with funds under our credit agreements, will provide sufficient resources to meet our present and future working capital and cash requirements for at least the next twelve months. We also believe that our longer-term working capital, planned expenditures and other general funding requirements will be satisfied through cash flows from operations and, to the extent necessary, from our borrowing facilities. 45 Table of Contents Accounting Standards Recently Issued See Note 1 of the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements, including the anticipated dates of adoption and the effects on our consolidated financial position and results of operations. Critical Accounting Policies and Estimates Critical accounting policies are those that are important to our financial condition and require management's most difficult, subjective or complex judgments. Different amounts would be reported under different operating conditions or under alternative assumptions. See Management's Discussion and Analysis of Financial Condition and Results from Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 for a complete discussion. 46 Table of Contents Item 3. Quantitative and Qualitative Disclosures About Market Risk For a description of our market risks, see Part II, Item 7A. "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. No material changes have occurred to our market risks since June 30, 2024. 47 Table of Contents